Your browser doesn't support javascript.
loading
Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors.
Metelo, Ana M; Jozwik, Agnieszka; Luong, Le Anh; Dominey-Foy, Delaney; Graham, Charlotte; Attwood, Charlotte; Inam, Shafqat; Dunlop, Alan; Sanchez, Katy; Cuthill, Kirsty; Rice, Carmel; Streetly, Matthew; Bentley, Trevor; Boldajipour, Bijan; Sommer, Cesar; Sasu, Barbra; Benjamin, Reuben.
Afiliación
  • Metelo AM; Comprehensive Cancer Center, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
  • Jozwik A; Comprehensive Cancer Center, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
  • Luong LA; King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Dominey-Foy D; Comprehensive Cancer Center, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
  • Graham C; Comprehensive Cancer Center, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
  • Attwood C; Comprehensive Cancer Center, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
  • Inam S; King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Dunlop A; Comprehensive Cancer Center, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
  • Sanchez K; King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Cuthill K; King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Rice C; King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Streetly M; King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Bentley T; King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Boldajipour B; King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Sommer C; Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Sasu B; Allogene Therapeutics Inc., South San Francisco, California.
  • Benjamin R; Pfizer Inc., South San Francisco, California.
Cancer Res Commun ; 2(3): 158-171, 2022 03.
Article en En | MEDLINE | ID: mdl-36874402
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Receptores Quiméricos de Antígenos / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Res Commun Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Receptores Quiméricos de Antígenos / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Res Commun Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido